RE: Risks to AVA6000 success16 Nov 2023 11:49
Great post DTW
The 2 weekly trial will be first line STS too (I know BV doesn't agree), so should be seeing more efficacy signals
In terms of risk, I think your summary covers it. The chances are the molecule isn't going to suddenly be found to be toxic in a wider application.